A new clinical trial finds a “morning after” dose of a common antibiotic can greatly lower the chances of sexually transmitted bacterial infections in high-risk people.
[print-me /]
Tags: National Health News
[print-me /]
A new clinical trial finds a “morning after” dose of a common antibiotic can greatly lower the chances of sexually transmitted bacterial infections in high-risk people.
